메뉴 건너뛰기




Volumn 32, Issue 6, 2013, Pages 763-768

A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

EID: 84878233068     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1803-7     Document Type: Review
Times cited : (31)

References (28)
  • 1
    • 0347694556 scopus 로고    scopus 로고
    • Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid
    • 14711073 10.1016/S0891-5520(03)00065-5
    • Craig WA (2003) Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17:479-501
    • (2003) Infect Dis Clin North Am , vol.17 , pp. 479-501
    • Craig, W.A.1
  • 2
    • 66449092115 scopus 로고    scopus 로고
    • A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics
    • 19384201 10.1097/CCM.0b013e3181a0054d 1:CAS:528:DC%2BD1MXmtVKlu7g%3D
    • Roberts JA, Webb S, Paterson D, Ho KM, Lipman J (2009) A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 37:2071-2078
    • (2009) Crit Care Med , vol.37 , pp. 2071-2078
    • Roberts, J.A.1    Webb, S.2    Paterson, D.3    Ho, K.M.4    Lipman, J.5
  • 3
    • 84859170733 scopus 로고    scopus 로고
    • Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: Systematic review and meta-analysis
    • 22028203 10.1093/jac/dkr442 1:CAS:528:DC%2BC3MXhs1CqtLnO
    • Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N (2012) Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 67:17-24
    • (2012) J Antimicrob Chemother , vol.67 , pp. 17-24
    • Cataldo, M.A.1    Tacconelli, E.2    Grilli, E.3    Pea, F.4    Petrosillo, N.5
  • 5
    • 77950303985 scopus 로고    scopus 로고
    • Nationwide implementation of antibiotic management teams in Belgian hospitals: A self-reporting survey
    • Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee 20053695 10.1093/jac/dkp470
    • Van Gastel E, Costers M, Peetermans WE, Struelens MJ; Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee (2010) Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 65:576-580
    • (2010) J Antimicrob Chemother , vol.65 , pp. 576-580
    • Van Gastel, E.1    Costers, M.2    Peetermans, W.E.3    Struelens, M.J.4
  • 6
    • 78049244903 scopus 로고    scopus 로고
    • Importance of infusion volume and pump characteristics in extended administration of β-lactam antibiotics
    • 20823285 10.1128/AAC.00754-10 1:CAS:528:DC%2BC3cXhsVCitrnO
    • Claus B, Buyle F, Robays H, Vogelaers D (2010) Importance of infusion volume and pump characteristics in extended administration of β-lactam antibiotics. Antimicrob Agents Chemother 54:4950
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 4950
    • Claus, B.1    Buyle, F.2    Robays, H.3    Vogelaers, D.4
  • 7
    • 34547578647 scopus 로고    scopus 로고
    • Peripheral line dead space: An unrecognised phenomenon?
    • 17652677 10.1136/emj.2007.046250
    • Geggie D, Moore D (2007) Peripheral line dead space: an unrecognised phenomenon? Emerg Med J 24:558-559
    • (2007) Emerg Med J , vol.24 , pp. 558-559
    • Geggie, D.1    Moore, D.2
  • 12
    • 34548401204 scopus 로고    scopus 로고
    • Continuous infusion of beta-lactams
    • 17762242 10.1097/MCC.0b013e3282e2a98f
    • Mouton JW, Vinks AA (2007) Continuous infusion of beta-lactams. Curr Opin Crit Care 13:598-606
    • (2007) Curr Opin Crit Care , vol.13 , pp. 598-606
    • Mouton, J.W.1    Vinks, A.A.2
  • 13
    • 72449120921 scopus 로고    scopus 로고
    • First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
    • 20018492 10.1016/j.ijantimicag.2009.10.008 1:CAS:528:DC%2BD1MXhs1WltbrE
    • Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J (2010) First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents 35:156-163
    • (2010) Int J Antimicrob Agents , vol.35 , pp. 156-163
    • Roberts, J.A.1    Kirkpatrick, C.M.2    Roberts, M.S.3    Dalley, A.J.4    Lipman, J.5
  • 15
    • 84856248934 scopus 로고    scopus 로고
    • Simple approach to improving vancomycin dosing in intensive care: A standardised loading dose results in earlier therapeutic levels
    • 22276559 10.1111/j.1445-5994.2011.02459.x 1:CAS:528:DC%2BC38Xjslejtbk%3D
    • Truong J, Levkovich BJ, Padiglione AA (2012) Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J 42:23-29
    • (2012) Intern Med J , vol.42 , pp. 23-29
    • Truong, J.1    Levkovich, B.J.2    Padiglione, A.A.3
  • 16
    • 82955212736 scopus 로고    scopus 로고
    • Improving vancomycin prescription in critical illness through a drug use evaluation process: A weight-based dosing intervention study
    • 22024354 10.1016/j.ijantimicag.2011.08.017
    • Li J, Udy AA, Kirkpatrick CM, Lipman J, Roberts JA (2012) Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study. Int J Antimicrob Agents 39:69-72
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 69-72
    • Li, J.1    Udy, A.A.2    Kirkpatrick, C.M.3    Lipman, J.4    Roberts, J.A.5
  • 17
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • 19106348 10.2146/ajhp080434 1:CAS:528:DC%2BD1MXhs1Gmtrs%3D
    • Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82-98
    • (2009) Am J Health Syst Pharm , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3    Moellering, Jr.R.4    Craig, W.5    Billeter, M.6    Dalovisio, J.R.7    Levine, D.P.8
  • 20
    • 84863807810 scopus 로고    scopus 로고
    • Subtherapeutic initial beta-lactam concentrations in select critically ill patients: Association between augmented renal clearance and low trough drug concentrations
    • 22194591 10.1378/chest.11-1671 1:CAS:528:DC%2BC38Xht1GmtrvL
    • Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39
    • (2012) Chest , vol.142 , pp. 30-39
    • Udy, A.A.1    Varghese, J.M.2    Altukroni, M.3    Briscoe, S.4    McWhinney, B.C.5    Ungerer, J.P.6    Lipman, J.7    Roberts, J.A.8
  • 21
    • 66149108761 scopus 로고    scopus 로고
    • Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients
    • 19223642 10.1128/AAC.01149-08 1:CAS:528:DC%2BD1MXlvVGgtLo%3D
    • Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, Viale P (2009) Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 53:1863-1867
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1863-1867
    • Pea, F.1    Furlanut, M.2    Negri, C.3    Pavan, F.4    Crapis, M.5    Cristini, F.6    Viale, P.7
  • 22
    • 77349091306 scopus 로고    scopus 로고
    • Dosage adjustment of vancomycin in continuous infusion in critically-ill patients
    • 20074899 10.1016/j.annfar.2009.12.002 1:STN:280:DC%2BC3c7jsFOnsw%3D%3D
    • Carricajo A, Forgeot A, Morel J, Auboyer C, Zeni F, Aubert G (2010) Dosage adjustment of vancomycin in continuous infusion in critically-ill patients. Ann Fr Anesth Reanim 29:55-57
    • (2010) Ann Fr Anesth Reanim , vol.29 , pp. 55-57
    • Carricajo, A.1    Forgeot, A.2    Morel, J.3    Auboyer, C.4    Zeni, F.5    Aubert, G.6
  • 24
    • 45749083759 scopus 로고    scopus 로고
    • Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy
    • 18334494 10.1093/jac/dkn080 1:CAS:528:DC%2BD1cXnt1Smsrg%3D
    • Ingram PR, Lye DC, Tambyah PA, Goh WP, Tam VH, Fisher DA (2008) Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. J Antimicrob Chemother 62:168-171
    • (2008) J Antimicrob Chemother , vol.62 , pp. 168-171
    • Ingram, P.R.1    Lye, D.C.2    Tambyah, P.A.3    Goh, W.P.4    Tam, V.H.5    Fisher, D.A.6
  • 25
    • 80054681544 scopus 로고    scopus 로고
    • Vancomycin nephrotoxicity: Myths and facts
    • 21978980 1:STN:280:DC%2BC3Mfptlahtw%3D%3D
    • Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379-383
    • (2011) Neth J Med , vol.69 , pp. 379-383
    • Gupta, A.1    Biyani, M.2    Khaira, A.3
  • 26
    • 0037339053 scopus 로고    scopus 로고
    • Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units
    • 12615867 10.1093/jac/dkg134 1:CAS:528:DC%2BD3sXit12ltL0%3D
    • Baririan N, Chanteux H, Viaene E, Servais H, Tulkens PM (2003) Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 51:651-658
    • (2003) J Antimicrob Chemother , vol.51 , pp. 651-658
    • Baririan, N.1    Chanteux, H.2    Viaene, E.3    Servais, H.4    Tulkens, P.M.5
  • 27
    • 2342635820 scopus 로고    scopus 로고
    • Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis
    • 15189746 10.1016/S0149-2918(04)90051-3 1:CAS:528:DC%2BD2cXkvF2nt7Y%3D
    • Kuti JL, Nightingale CH, Knauft RF, Nicolau DP (2004) Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis. Clin Ther 26:493-501
    • (2004) Clin Ther , vol.26 , pp. 493-501
    • Kuti, J.L.1    Nightingale, C.H.2    Knauft, R.F.3    Nicolau, D.P.4
  • 28
    • 77953710477 scopus 로고    scopus 로고
    • Stability of meropenem and doripenem solutions for administration by continuous infusion
    • 20176578 10.1093/jac/dkq044 1:CAS:528:DC%2BC3cXks1Gnu7g%3D
    • Berthoin K, Le Duff CS, Marchand-Brynaert J, Carryn S, Tulkens PM (2010) Stability of meropenem and doripenem solutions for administration by continuous infusion. J Antimicrob Chemother 65:1073-1075
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1073-1075
    • Berthoin, K.1    Le Duff, C.S.2    Marchand-Brynaert, J.3    Carryn, S.4    Tulkens, P.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.